Danni Wang | Medical Microbiology | Best Researcher Award Published on 13/09/202515/09/2025 by Health Scientists Assoc. Prof. Dr. Danni Wang | Medical Microbiology | Best Researcher Award Associate professor | Shanghai Jiao Tong University School of Medicine | China Dr. Danni Wang is a biomedical researcher currently serving as a faculty member at a leading research institute in China, specializing in host–pathogen interactions and epigenetic regulation of infectious diseases. She earned her Ph.D. in Microbiology and Immunology after completing undergraduate studies in Biological Sciences, building a strong foundation in molecular biology and medical research. Her research focuses on the role of post-translational histone modifications, including acetylation and lactylation, in bacterial infection, immune evasion, and tumorigenesis, with particular emphasis on pathogens such as Salmonella, Shigella, and Fusobacterium nucleatum. Dr. Wang has published extensively in high-impact journals, with recent contributions in Nature Communications, Cell Reports, Nucleic Acids Research, PLoS Pathogens, and Virulence, where her studies have advanced understanding of how bacterial factors manipulate host immunity and disease progression. Her work on histone modifications in infection and cancer has been recognized through competitive funding from the National Natural Science Foundation of China and key laboratory grants. Among her notable honors, she has received recognition for her innovative approaches to uncovering the molecular mechanisms of host–pathogen interplay. In addition to her research achievements, Dr. Wang actively contributes to the scientific community as a reviewer and editorial board member for leading international journals in microbiology, infectious diseases, and molecular biology. With a career dedicated to bridging infection biology and epigenetic regulation, she continues to shape new therapeutic strategies targeting bacterial infections and related pathologies. Profile: Scopus Publications 1. Shao, D., Yao, Y.-F., & Wang, D. (2025). Ferroptosis and iron-based therapies in Pseudomonas aeruginosa infections: From pathogenesis to treatment. Virulence, 16(1), 2553787. 2. Zhou, X., Zhang, H., Wang, Y., Wang, D., Lin, Z., Zhang, Y., Tang, Y., Liu, J., Yao, Y.-F., Zhang, Y., & Pan, L. (2025). Shigella effector IpaH1.4 subverts host E3 ligase RNF213 to evade antibacterial immunity. Nature Communications, 16(1), 3099. 3. Zhou, N., Yu, J., Liu, X., Li, C., Tang, H., Lyu, L., Wu, C., Chen, Y., Zhang, J., Ni, J., Wang, D., Tao, J., Wu, W., Zhang, Y., Feng, Y., Chao, Y., Lu, J., He, P., & Yao, Y.-F. (2025). Within-host evolution of a transcriptional regulator contributes to the establishment of chronic Pseudomonas aeruginosa infection. Cell Reports, 44(1). 4. Yu, J., Tang, H., Zhou, N., Wang, Z., Huang, W., Chen, Y., Wang, D., Ni, J., Lu, J., & Yao, Y.-F. (2024). Dietary L-arabinose-induced gut dysbiosis exacerbates Salmonella infection outcome. mSystems, 9(8). 5. Ni, J., Li, S., Lai, Y., Wang, Z., Wang, D., Fan, Y., Tan, Y., Lu, J., & Yao, Y.-F. (2023). Global profiling of ribosomal protein acetylation reveals essentiality.
Dr. Danni Wang is a biomedical researcher currently serving as a faculty member at a leading research institute in China, specializing in host–pathogen interactions and epigenetic regulation of infectious diseases. She earned her Ph.D. in Microbiology and Immunology after completing undergraduate studies in Biological Sciences, building a strong foundation in molecular biology and medical research. Her research focuses on the role of post-translational histone modifications, including acetylation and lactylation, in bacterial infection, immune evasion, and tumorigenesis, with particular emphasis on pathogens such as Salmonella, Shigella, and Fusobacterium nucleatum. Dr. Wang has published extensively in high-impact journals, with recent contributions in Nature Communications, Cell Reports, Nucleic Acids Research, PLoS Pathogens, and Virulence, where her studies have advanced understanding of how bacterial factors manipulate host immunity and disease progression. Her work on histone modifications in infection and cancer has been recognized through competitive funding from the National Natural Science Foundation of China and key laboratory grants. Among her notable honors, she has received recognition for her innovative approaches to uncovering the molecular mechanisms of host–pathogen interplay. In addition to her research achievements, Dr. Wang actively contributes to the scientific community as a reviewer and editorial board member for leading international journals in microbiology, infectious diseases, and molecular biology. With a career dedicated to bridging infection biology and epigenetic regulation, she continues to shape new therapeutic strategies targeting bacterial infections and related pathologies. Profile: Scopus Publications 1. Shao, D., Yao, Y.-F., & Wang, D. (2025). Ferroptosis and iron-based therapies in Pseudomonas aeruginosa infections: From pathogenesis to treatment. Virulence, 16(1), 2553787. 2. Zhou, X., Zhang, H., Wang, Y., Wang, D., Lin, Z., Zhang, Y., Tang, Y., Liu, J., Yao, Y.-F., Zhang, Y., & Pan, L. (2025). Shigella effector IpaH1.4 subverts host E3 ligase RNF213 to evade antibacterial immunity. Nature Communications, 16(1), 3099. 3. Zhou, N., Yu, J., Liu, X., Li, C., Tang, H., Lyu, L., Wu, C., Chen, Y., Zhang, J., Ni, J., Wang, D., Tao, J., Wu, W., Zhang, Y., Feng, Y., Chao, Y., Lu, J., He, P., & Yao, Y.-F. (2025). Within-host evolution of a transcriptional regulator contributes to the establishment of chronic Pseudomonas aeruginosa infection. Cell Reports, 44(1). 4. Yu, J., Tang, H., Zhou, N., Wang, Z., Huang, W., Chen, Y., Wang, D., Ni, J., Lu, J., & Yao, Y.-F. (2024). Dietary L-arabinose-induced gut dysbiosis exacerbates Salmonella infection outcome. mSystems, 9(8). 5. Ni, J., Li, S., Lai, Y., Wang, Z., Wang, D., Fan, Y., Tan, Y., Lu, J., & Yao, Y.-F. (2023). Global profiling of ribosomal protein acetylation reveals essentiality.